Understanding costs and coverage helps patients plan and access treatment effectively
During short-term follow-up in the chronic AIH cohort (median 24 months), 78% of patients with baseline high IgG remained with elevated IgG which led to significantly more treatment increase in this group (17 vs 3% in the normal IgG group, p=0.015)
A new study published by the University of Rochester Medical Center on July 23, 2025, adds to growing concerns about the health impacts of PFAS, or per- and polyfluoroalkyl substances, by identifying specific immune system alterations in infants exposed to the chemicals during pregnancy
Originally approved for diabetes, GLP-1 drugs are positively used in the management of weight loss, cardiovascular risk, fatty liver disease, and neurodegenerative conditions
DPP-4 is indispensable for immune responses, T-cell activation, and maturation, and it often functions as a sole receptor of DPP-4 in isolation from its catalytic action [12]
doi:10.1007/s00125-017-4491-0
